TITLE

Thyroid Hormone Changes in Early Kidney Transplantation and Its Correlation with Delayed

AUTHOR(S)
Hekmat, Reza; Javadi, Zahra; Javan, Malihe Layghian; Sanadgol, Hooshang; Gholami, Farhad; Mohebbi, Mahmoud; Zeraati, Abbas Ali; Ahmadnia, Hassan; Tabarraiei, Hamid; Baradaran, Mahsa; Mojahedi, Mohammad Javad
PUB. DATE
January 2010
SOURCE
Urology Journal;Nov2010, Vol. 7 Issue 1, p30
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Thyroid hormones affect kidney function and may alter with changes in kidney function, as well. We evaluated changes in serum levels of triiodothyronine (T3), thyroxin (T4), and thyroid-stimulating hormone (TSH) early after kidney transplantation and their relationship with delayed graft function (DGF). Materials and Methods: Fifty-five consecutive kidney allograft recipients were enrolled in the study. Serum levels of T3, T4, and TSH were measured on the day before transplantation, and also on posttransplant days 1, 3, 7, 14, and 21. Results were compared between patients with a normal allograft function and those with DGF. Results: The mean T3 level decreased from 110.41 ± 49.79 ng/dL before transplantation to 80.78 ± 51.42 ng/dL on the 1st day after transplantation (P = .04), while T4 reduction reached a significant level on the 3rd day after transplantation (8.27 ± 3.27μg/dL to 5.50 ± 2.57 μg/dL, P = .004). Patients with DGF experienced a significantly greater decrease in the serum level of T3 at the end of the 1st week after transplantation compared with patients with normal kidney function (P = .02). This significant decrease in T3 continued until the end of the 2nd week. Serum levels of T4 reduced comparably in the two groups, until the end of the 1st week, when it showed a significantly more reduction in the patients with DGF (P = .04). Conclusion: Both T3 and T4 reduced early after kidney transplantation, and this reduction was significantly more prominent in those with DGF. This is compatible with a consequence rather than a cause of DGF, explained in the setting of sick euthyroid syndrome.
ACCESSION #
48637369

 

Related Articles

  • Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation. Ponticelli, Claudio // Nephrology Dialysis Transplantation;Jan2010, Vol. 25 Issue 1, p25 

    The article discusses the recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation. The success of renal transplantation may be impaired by the frequent risk of recurrence of the disease. Several factors have been reported to be associated with an increased risk of...

  • Rituximab for plasma exchange-dependent recurrent focal segmental glomerulosclerosis after renal transplantation. Deegen, Jeroen K. J.; Wetzels, Jack F. M. // NDT Plus;Apr2008, Vol. 1 Issue 2, p85 

    The article describes the case of a 24-year-old female with recurrent focal segmental glomerolusclerosis (FSGS) after renal transplantation. The patient was treated with rituximab after unsuccessful treatment with prednisone and plasma exchange. Rituximab was reported to be an effective...

  • Focal Segmental Glomerulosclerosis and Kidney Transplantation. Gheith, Osama; Hassan, Rashad // Iranian Journal of Kidney Diseases;Jul2013, Vol. 7 Issue 4, p257 

    The recurrence rate of focal segmental glomerulosclerosis after kidney transplantation is ranging between 20% and 40%. Focal segmental glomerulosclerosis is associated with poor graft survival. In this review, the etiology, pathogenesis, clinicopathological features, risk factors of recurrence,...

  • A study of interobserver reproducibility of morphologic lesions of focal segmental glomerulosclerosis. Meehan, Shane; Chang, Anthony; Gibson, Ian; Kim, Lisa; Kambham, Neeraja; Laszik, Zoltan // Virchows Archiv;Feb2013, Vol. 462 Issue 2, p229 

    The morphology of focal segmental glomerulosclerosis (FSGS) includes collapsing, cellular, and sclerosing forms. The Columbia Working Classification of FSGS divides these into collapsing (COLL), cellular (CELL), tip lesion (TIP), perihilar (PH), and not otherwise specified (NOS) morphologic...

  • Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation. Cara Fuentes, Gabriel; Garcia Meseguer, Carmen; Peña Carrion, Antonia; Melgosa Hijosa, Marta; Garcia-Pose, Araceli; Alonso Melgar, Angel; Navarro Torres, Mercedes // Pediatric Nephrology;Mar2010, Vol. 25 Issue 3, p529 

    Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation can limit graft survival. Despite new immunosuppressive agents, the incidence of recurrence remains relatively high. To identify risk factors for recurrence and efficacy of treatment, we reviewed the outcome of...

  • Black Race Worsens Renal Tx Outcomes.  // Renal & Urology News;Jan2012, Vol. 11 Issue 1, p22 

    The article presents the findings of two studies which showed the association of African-American (AA) race with worse renal transplant outcomes among patients with lupus nephritis and focal segmental glomerulosclerosis (FSGS). One study revealed that AA population is at increased risk for both...

  • Successful treatment of spontaneous kidney graft decapsulation 18 years after renal transplantation: a case report. Myhre, Hans-Arne; Øyen, Ole; Kårbø, Øyvind; Midtvedt, Karsten // NDT Plus;Feb2010, Vol. 3 Issue 1, p100 

    A letter is presented about the case of a 41-year-old Caucasian male who was diagnosed with end-stage renal failure with chronic glomerulonephritis in 1989. The patient underwent renal transplant in 1990, which initially did not show any complications. However, 18 years after the transplant, the...

  • Treatment of Recurrent Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplant Recipients: Effect of Rituximab. Sethna, Christine; Benchimol, Corinne; Hotchkiss, Hilary; Frank, Rachel; Infante, Lulette; Vento, Suzanne; Trachtman, Howard // Journal of Transplantation;2011, p1 

    Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation is a complication that often leads to graft loss. There is no consensus on the optimal treatment of recurrent FSGS. Rituximab, a monoclonal antibody to CD20, may be a useful treatment of this complication....

  • Resurgence of membranous nephropathy in African Americans in inner city Chicago. Kraus, Mark A.; Punj, Shweta; Cimbaluk, David; Hart, Peter D. // Clinical Kidney Journal;Aug2013, Vol. 6 Issue 4, p373 

    Background. It is well established that the incidence of focal segmental glomerular sclerosis (FSGS) increased from 1970-1990 to become the leading primary glomerular disease in patients of African descent. Methods. To determine whether this trend has continued in the past years in Chicago,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics